COVID-19 shapes Indian pharma deals landscape, reveals GlobalData report EP News Bureau Sep 21, 2021 Between 2019 and 2020, the deal number increased by 22 per cent, likely triggered by the COVID-19 pandemic
Deal value in pharma industry decreases by 67.2 per cent in August: Globalata EP News Bureau Sep 8, 2021 The industry reported 109 venture capital (VC) deals worth $4.5 billion in August 2021, compared to the last 12-month average of…
37 M&A deals worth $18.9 bn in Aug 2019: GlobalData Report EP News Bureau Sep 16, 2019 Amgen’s proposed acquisition of Otezla from Celgene for $13.4 billion provides 71 per cent to deal value
